CTBP1 and breast carcinoma: Lastly, to validate that p53 serves as a switch in miR-644a/CTBP1/p53 axis in breast cancer, we checked the downstream effects of miR-644a in 6 different breast cancer cell lines (three p53-wt and three p53-mut) after forced miR-644a expression using mimics.